Solution for X-linked Hypophosphatemia (XLH)
CRYSViTA
XLH causes the body to lose phosphorus, an essential mineral for bone health. CRYSVITA, the only FDA-approved treatment for XLH in adults and children 6 months of age or older, helps increase phosphorus levels in the body, restoring them to normal.
In people with XLH:
- The body produces an excess of fibroblast growth factor 23 (FGF23).
- This excess FGF23 causes the kidneys to release too much phosphorus through the urine.
- The resulting low phosphorus levels can weaken bones.
CRYSVITA helps alleviate patients’ symptoms and bring them closer to a healthier, happier life!
























